Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |